Anupam Rasayan India has signed definitive agreement to acquire 100% equity stake in Jayhawk Fine Chemicals Corporation (Jayhawk) (part of the CABB group), a U.S. based specialty chemical company, for a purchase consideration of around $150 million. The purchase consideration accounts for payment against the equity value of Jayhawk and existing loans payable to the exiting shareholders. Considering around $16 million of cash and cash-like items for Jayhawk as of June 2025, the purchase consideration translates to an enterprise value of around $134 million.
The acquisition will be financed through a mix of internal accruals, debt and quasi equity from a leading global investment management firm with an AUM in excess of $100 billion. This acquisition shall be EPS accretive for Anupam.
This acquisition represents a transformative step in Anupam Rasayan’s long-term strategy to expand its global CDMO presence and establish a strong foothold in the U.S. & global specialty chemicals market.
Anupam Rasayan India is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India.
